WP
NUVB icon

Woodline Partners’s Nuvation Bio NUVB Stock Holding History

Woodline Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.12M Buy
960,414
+2,500
+0.3% +$13.9K 0.02% 693
2025
Q4 		$8.58M Buy
957,914
+2,500
+0.3% +$15.5K 0.03% 498
2025
Q3 		$3.54M Buy
+955,414
New +$2.6M 0.02% 636

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Woodline Partners's NUVB Position: Q1 2026 in Review

Woodline Partners increased its Nuvation Bio (NUVB) stake by 0.26% in Q1 2026, buying an estimated $13.9K and bringing the position to 960,414 shares worth $4.12M. The position accounts for 0.02% of the portfolio, ranked #693.

Woodline Partners first reported a position in NUVB in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.58M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Woodline Partners held 960,414 shares of Nuvation Bio worth $4.12M as of Q1 2026.
  • Woodline Partners bought 2,500 Nuvation Bio shares in Q1 2026, an estimated $13.9K.
  • Nuvation Bio made up 0.02% of Woodline Partners's portfolio in Q1 2026, its #693 holding.
  • Woodline Partners first reported a position in Nuvation Bio in Q3 2025 and has held it in 3 quarters since.
  • Woodline Partners's Nuvation Bio position peaked at $8.58M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.